Usana Health Sciences (USNA) Retained Earnings (2011 - 2026)

Usana Health Sciences (USNA) has reported Retained Earnings for 16 consecutive years, with $451.9 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, Retained Earnings fell 4.68% year-over-year to $451.9 million in Q3 2026; TTM through Jul 2026 was $451.9 million, a 4.68% decrease from a year earlier, with the FY2026 full-year figure at $465.7 million, down 2.76% from the prior year.
• Retained Earnings was $451.9 million for Q3 2026 at Usana Health Sciences, down from $473.2 million in the prior quarter.
• Over five years, Retained Earnings peaked at $478.9 million in Q4 2024 and troughed at $344.6 million in Q1 2022.
• A 5-year average of $432.4 million and a median of $451.9 million in 2026 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings retreated 9.97% in 2022 and climbed 18.93% in 2023, its largest moves.
• Over 5 years, Retained Earnings stood at $391.6 million in 2022, then rose by 13.68% to $445.2 million in 2023, then advanced by 7.58% to $478.9 million in 2024, then fell by 2.39% to $467.5 million in 2025, then slipped by 3.35% to $451.9 million in 2026.
• The last three Retained Earnings figures came in at $451.9 million (Q3 2026), $473.2 million (Q2 2026), and $465.7 million (Q1 2026), per Business Quant data.